Seattle-based Fred Hutch Cancer Center named Nicole Fleming, MD, as its inaugural deputy chief medical officer. For the last 13 years, Dr. Fleming worked at The University of Texas MD Anderson Cancer ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

In October 2024, we provided updated results from our IMMUNOCERV Phase 2 clinical trial in locally advanced cervical cancer patients treated with Versamune ® HPV and chemoradiotherapy presented at the ...

Be Nutty: “Nuts are an excellent choice for controlling inflammation,” say experts at the University of North Carolina. “They ...

Nektar continues to make progress with rezpegaldesleukin, with results from phase 2 atopic dermatitis study expected in H1'25 ...

In April 2009, Heaven & Hell released their sole studio album, The Devil You Know, to widespread acclaim. It should have been ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Researchers have developed a non-addictive painkiller that remains inactive until it reaches sites of chronic pain. Instead of dulling the nerves that send the pain signals like other analgesics, this ...

Dr. Naoto Ueno took over as its executive director more than a year ago and has been working intently on the center's future.

Frustrated, Sedhom, a medical oncologist at the University of Pennsylvania Perelman ... said Fumiko Chino, MD, an associate ...

While it affects every county, city, town and family, Stacker compiled the counties with the highest cancer rates in Texas ...

Whether they’re making a difference in radiation treatments for cancer patients or ensuring safe and effective diagnostic ...